Comparative evaluation of five β-Lactamase inhibitors in combination with β-Lactams against multidrug-resistant Mycobacterium tuberculosis in vitro.

PMID: 402959722025

Key Findings

Mutations in blaC were associated with altered susceptibility to β-lactams in combination with β-lactamase inhibitors.

0gene entries

1mutation entry

AMR Mutations

Gene	Protein Change	Nucleotide Change	Mechanism	Organism	Resistance To	Database	Validation Status
blaC	S111R	-	-	-	Meropenem	Reslit	-